Meftal-Spas Suspension is a combination pharmaceutical formulation containing Dicyclomine 10 mg and Simethicone 40 mg per dose, designed for the symptomatic relief of gastrointestinal spasms and associated discomfort. Dicyclomine, an anticholinergic agent, acts by inhibiting the muscarinic action of acetylcholine on smooth muscles of the gastrointestinal tract, thereby reducing muscle spasms and abdominal cramping. Simethicone, an anti-foaming agent, facilitates the coalescence of gas bubbles in the gastrointestinal tract, promoting their easier expulsion and alleviating symptoms of bloating and flatulence. This suspension is indicated for conditions such as irritable bowel syndrome, functional bowel disorders, and other gastrointestinal spasmodic conditions accompanied by excessive gas. The combination provides a dual mechanism of action, addressing both muscle spasms and gas-related discomfort, improving patient comfort and quality of life. Meftal-Spas Suspension is typically administered orally, with dosage tailored according to the severity of symptoms and patient response. It is generally well tolerated; however, caution is advised in patients with known hypersensitivity to anticholinergics or those with conditions such as glaucoma, myasthenia gravis, or obstructive uropathy. Consultation with a healthcare professional is recommended prior to use to ensure appropriate indication and dosing.